Editorial: Duration of heart failure and the risk of atrial fibrillation: Different mechanisms at different times?

Cardiovascular Research

Volumn 84, Issue 2, 2009, Pages 180-181

  Rankin, Andrew C ^a   Workman, Antony J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; KV CHANNEL INTERACTING PROTEIN; CALCIUM CHANNEL L TYPE; POTASSIUM CHANNEL;

ACTION POTENTIAL; CARDIOVASCULAR RISK; DISEASE DURATION; DISEASE PREDISPOSITION; EDITORIAL; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART MUSCLE REFRACTORY PERIOD; HEART REPOLARIZATION; HEART VENTRICLE PACING; HUMAN; ION CURRENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; CALCIUM SIGNALING; CHRONIC DISEASE; DRUG EFFECT; HEART ATRIUM FUNCTION; HEART CONTRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART MUSCLE CONDUCTION SYSTEM; METABOLISM; NOTE; PATHOLOGY; PATHOPHYSIOLOGY; REFRACTORY PERIOD; RISK FACTOR; TIME;

ACTION POTENTIALS; ANIMALS; ATRIAL FIBRILLATION; ATRIAL FUNCTION, LEFT; CALCIUM CHANNELS, L-TYPE; CALCIUM SIGNALING; CHRONIC DISEASE; HEART CONDUCTION SYSTEM; HEART FAILURE; HUMANS; MYOCARDIAL CONTRACTION; MYOCARDIUM; POTASSIUM CHANNELS; REFRACTORY PERIOD, ELECTROPHYSIOLOGICAL; RISK FACTORS; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 71549131313     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvp299     Document Type: Editorial

References (14)

1. Anter E, Jessup M, Callans DJ. Atrial fibrillation and heart failure: treatment considerations for a dual epidemic. Circulation 2009;119:2516-2525.
2. Workman AJ, Kane KA, Rankin AC. Cellular bases for human atrial fibrillation. Heart Rhythm 2008;5:S1-S6.
3. Li D, Melnyk P, Feng J, Wang Z, Petrecca K, Shrier A et al. Effects of experimental heart failure on atrial cellular and ionic electrophysiology. Circulation 2000;101:2631-2638.
4. Stambler BS, Fenelon G, Shepard RK, Clemo HF, Guiraudon CM. Characterization of sustained atrial tachycardia in dogs with rapid ventricular pacing-induced heart failure. J Cardiovasc Electrophysiol 2003;14: 499-507. (Pubitemid 36583911)
5. Li D, Fareh S, Leung TK, Nattel S. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation 1999; 100:87-95.
6. Workman AJ, Pau D, Redpath CJ, Marshall GE, Russell JA, Norrie J et al. Atrial cellular electrophysiological changes in patients with ventricular dysfunction may predispose to AF. Heart Rhythm 2009;6:445-451.
7. Sridhar A, Nishijima Y, Terentyev D, Khan M, Terentyeva R, Hamlin RL et al. Chronic heart failure and the substrate for atrial fibrillation. Cardi-ovasc Res. 2009;84:227-236.
8. Ramirez RJ, Nattel S, Courtemanche M. Mathematical analysis of canine atrial action potentials: rate, regional factors, and electrical remodeling. Am J Physiol Heart Circ Physiol 2000;279:H1767-H1785.
9. Workman AJ, Kane KA, Rankin AC. The contribution of ionic currents to changes in refractoriness of human atrial myocytes associated with chronic atrial fibrillation. Cardiovasc Res 2001;52:226-235.
10. Thomsen MB, Sosunov EA, Anyukhovsky EP, Ozgen N, Boyden PA, Rosen MR. Deleting the accessory subunit KChIP2 results in loss of I(to,f) and increased I(K,slow) that maintains normal action potential configuration. Heart Rhythm 2009;6:370-377.
11. Yeh YH, Wakili R, Qi XY, Chartier D, Boknik P, Kaab S et al. Calcium-handling abnormalities underlying atrial arrhythmogenesis and contractile dysfunction in dogs with Congestive Heart Failure. Circ Arrhythmia Electrophysiol 2008;1:93-102.
12. Ehrlich JR, Hohnloser SH, Nattel S. Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence. Eur Heart J 2006;27:512-518.
13. Li D, Shinagawa K, Pang L, Leung TK, Cardin S, Wang Z et al. Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation 2001;104:2608-2614.
14. Sanders P, Morton JB, Davidson NC, Spence SJ, Vohra JK, Sparks PB et al. Electrical remodeling of the atria in congestive heart failure: electro-physiological and electroanatomic mapping in humans. Circulation 2003;108:1461-1468.